246 related articles for article (PubMed ID: 30536305)
21. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
22. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.
Wang Q; Chen Q
J Cancer Res Ther; 2018 Jun; 14(Supplement):S405-S409. PubMed ID: 29970697
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of long non-coding RNA HOST2 expression and its tumor-promotive function in human osteosarcoma.
Qi XD; Xu SY; Song Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):921-927. PubMed ID: 29509239
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
Li F; Cao L; Hang D; Wang F; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
26. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
27. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
[TBL] [Abstract][Full Text] [Related]
28. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Zhang Y; Meng W; Cui H
Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA DNAJC3-AS1 promotes osteosarcoma progression via its sense-cognate gene DNAJC3.
Liang R; Liu Z; Chen Z; Yang Y; Li Y; Cui Z; Chen A; Long Z; Chen J; Lu J; Huang B; Li Q
Cancer Med; 2019 Feb; 8(2):761-772. PubMed ID: 30652414
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
31. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
Liu F; Xing L; Zhang X; Zhang X
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasis.
Ju L; Zhou YM; Yang GS
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4445-4451. PubMed ID: 27874956
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of long noncoding RNA CCAL predicts poor patient prognosis and promotes tumor metastasis in osteosarcoma.
Zhou DK; Yang XW; Li H; Yang Y; Zhu ZJ; Wu N
Int J Biol Markers; 2017 Mar; 32(1):e108-e112. PubMed ID: 28009431
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
[TBL] [Abstract][Full Text] [Related]
38. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Wang WW; Zhu WG; Yu CH; Tao GZ; Wu QQ; Song YQ; Pan P; Tong YS
Mol Carcinog; 2016 Dec; 55(12):2095-2105. PubMed ID: 26756568
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic significance of S100A4 expression in osteosarcoma.
Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
Zhang HH; Li AH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
